By invitation only
Control of Assistive Devices Via Brain-Computer Interface Technology
NCT06710626 · Neuralink Corp · Updated 5 June 2025
- What is being tested
- Assistive Robotic Arm
- For
- Tetraplegia/Tetraparesis; Amyotrophic Lateral Sclerosis (ALS); Quadriplegia; Spinal Cord Injury (SCI); Spinal Cord Injury Cervical
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages Not stated. About 3 people. The full rules are on the registry page.
- Where
- United States
- When
- Starts or started 25 Nov 2024, ends 25 May 2031. Registered 29 Nov 2024.
- Results
- None posted yet.
In the researchers' words
The CONVOY Study is a clinical trial designed to explore the feasibility of participants from the PRIME Study (NCT06429735) using the N1 Implant to control various assistive devices. The main goal is to determine whether participants can successfully modulate their brain activity to control devices, such as an Assistive Robotic Arm (ARA). This study will assess the effectiveness, consistency, and safety of neural control using the ARA and other assistive devices.
Sites
- Barrow Neurological InstitutePhoenix, Arizona, United States